Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Revenue (2023 - 2025)

Metagenomi (MGX) has disclosed Revenue for 3 consecutive years, with $3.9 million as the latest value for Q4 2025.

  • Quarterly Revenue fell 59.32% to $3.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.2 million through Dec 2025, down 51.79% year-over-year, with the annual reading at $25.2 million for FY2025, 51.79% down from the prior year.
  • Revenue for Q4 2025 was $3.9 million at Metagenomi, down from $8.7 million in the prior quarter.
  • The five-year high for Revenue was $20.0 million in Q2 2024, with the low at $3.9 million in Q4 2025.
  • Average Revenue over 3 years is $10.2 million, with a median of $10.4 million recorded in 2024.
  • The sharpest move saw Revenue skyrocketed 76.48% in 2024, then plummeted 63.02% in 2025.
  • Over 3 years, Revenue stood at $12.4 million in 2023, then decreased by 22.46% to $9.6 million in 2024, then plummeted by 59.32% to $3.9 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $3.9 million, $8.7 million, and $8.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.